It is still unclear whether the emerin levels in cancer are a dynamic representation of conditions in the tumor at a particular time, and thus a reflection of the response to transformed signaling pathways and microenvironmental conditions, or whether altered emerin levels in cancer are uncoupled from the normal regulatory mechanism and can independently initiate oncogenic changes. This evidence concerns the gene EMD and neoplasm.